| author name | recommending | commenting | favorite | papers | recom. | cited | |
|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 245 | 0 | 993 | [Update] | |
| 0 | 0 | 0 | 89 | 0 | 130 | [Update] | |
| 0 | 0 | 0 | 11 | 0 | 0 | [Update] |
Latest Paper:
Universiteit Maastricht, Vakgroep Farmacologie en Toxicologie, Maastricht, The Netherlands. a.bast@farmaco.unimaas.nl
Medical students in the Netherlands have the opportunity to follow an internship abroad. However, this is often at the expense of developing their competence, for example in situations where they do not learn abroad what they would have learnt had they followed the Dutch programme. An international internship should, therefore, not be obliged for all medical students.
Evi M Mercken,
Harry R Gosker,
Erica P Rutten,
Emiel F Wouters,
Aalt Bast,
Geja J Hageman,
Annemie M Schols
From the Departments of Respiratory Medicine (Ms. Mercken, and Drs. Gosker, Wouters, and Schols), Pharmacology and Toxicology (Dr. Bast), and Health Risk Analysis and Toxicology (Dr. Hageman), and the School for Nutrition, Toxicology, and Metabolism (NUTRIM)[Drs. Rutten and Wouters], Maastricht University, Maastricht, the Netherlands; and the Centre for Integrated Rehabilitation Organ Failure (CIRO)[Drs. Rutten and Wouters], Horn, the Netherlands.
BACKGROUND: The aim of this study was to disentangle the contribution of muscular vs pulmonary oxidative stress during endurance exercise in patients with COPD. METHODS: Fifteen COPD patients and 10 healthy age-matched controls performed a continuously submaximal single leg ergometer test (40% of peak workload) for 20 min or until they stopped (Tlim). Venous blood, urine samples and exhaled breath condensate were sampled before, immediately and 2h after exercise. RESULTS: Tlim was lower in COPD than controls (p < .01). No exercise-induced systemic inflammation (IL-6, TNF-alpha) was found in the groups. Urinary malondialdehyde (MDA) and uric acid (p < .05) were increased in COPD whereas erythrocyte GSSG/GSH tended to be increased in COPD compared to controls after exercise (p = .08). Despite the relatively low cardioventilatory response to this localized muscle exercise, hydrogen peroxide (H(2)O(2)) in breath condensate significantly increased in COPD (p < .01). NF-kappaB DNA binding activity of p50 in peripheral blood monocytes was elevated after exercise in both COPD (p < .01) and controls (p < .05), whereas p65 protein was not altered. CONCLUSION: COPD patients showed increased pulmonary and systemic oxidative stress after localized leg muscle exercise compared to healthy controls without evidence of increased levels of systemic inflammation.
Gertjan J M den Hartog,
Agnes W Boots,
Aline Adam-Perrot,
Fred Brouns,
Inge W C M Verkooijen,
Antje R Weseler,
Guido R M M Haenen,
Aalt Bast
Department of Pharmacology and Toxicology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Keywords:
Nuria Mateo Anson,
Emilia Selinheimo,
Rob Havenaar,
Anna-Marja Aura,
Ismo Mattila,
Pekka Lehtinen,
Aalt Bast,
Kaisa Poutanen,
Guido R M M Haenen
University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
Ferulic acid (FA) is the most abundant phenolic compound in wheat grain, mainly located in the bran. However, its bioaccessibility from the bran matrix is extremely low. Different bioprocessing techniques involving fermentation or enzymatic and fermentation treatments of wheat bran were developed aiming at improving the bioaccessibility of phenolic compounds in bran-containing breads. The bioaccessibility of ferulic acid, p-coumaric acid, and sinapic acid was assessed with an in vitro model of upper gastrointestinal tract (TIM-1). Colonic metabolism of the phenolic compounds in the nonbioaccessible fraction of the breads was studied with an in vitro model of human colon (TIM-2). The most effective treatment was the combination of enzymes and fermentation that increased the bioaccessibility of FA from 1.1% to 5.5%. The major colonic metabolites were 3-(3-hydroxyphenyl)propionic acid and 3-phenylpropionic acid. Bran bioprocessing increases the bioaccessibility of phenolic compounds as well as the colonic end metabolite 3-phenylpropionic acid.
Agnes W Boots,
Milena Hristova,
David I Kasahara,
Guido R M M Haenen,
Aalt Bast,
Albert van der Vliet
Pathology, University of Vermont, Burlington, VT 05405.
Activation of the NADPH oxidase homolog dual oxidase 1 (DUOX1) within the airway epithelium cells represents a key mechanism of innate airway host defense, through enhanced production of H2O2 mediating cellular signaling pathways that regulate the production of various inflammatory mediators. Production of the CXC chemokine interleukin (IL)-8/CXCL8 forms a common epithelial response to many diverse stimuli, including bacterial and viral triggers, environmental oxidants, and other biological mediators, suggesting the potential involvement of a common signaling pathway that may involve DUOX1-dependent H2O2 production. Following previous reports showing that DUOX1 is activated by extracellular ATP and purinergic receptor stimulation, the present studies demonstrate that airway epithelial IL-8 production in response to several bacterial stimuli involves ATP release and DUOX1 activation. ATP-mediated DUOX1 activation resulted in the activation of ERK1/2 and NF-B pathways, which was associated with epidermal growth factor (EGFR) ligand shedding by ADAM17 (a disintegrin and metalloproteinase-17). Although ATP-mediated ADAM17 activation and IL-8 release were not prevented by extracellular H2O2 scavenging by catalase, these responses were attenuated by intracellular scavengers of H2O2 or related oxidants, suggesting an intracellular redox signaling mechanism. Both ADAM17 activation and IL-8 release were suppressed by inhibitors of EGFR/ERK1/2 signaling, which can regulate ADAM17 activity by serine/threonine phosphorylation. Collectively, our results indicate that ATP-mediated DUOX1 activation represents a common response mechanism to several environmental stimuli, involving H2O2-dependent EGFR/ERK activation, ADAM17 activation and EGFR ligand shedding, leading to amplified epithelial EGFR activation and IL-8 production.
Department of Nuclear Medicine, Maastricht University Medical Centre, The Netherlands.
Some patients with sarcoidosis can have cardiac involvement. Impairment of the cardiac sympathetic nerve activity is seen in about 50% of the sarcoidosis patients with small fiber neuropathy. In this case we present a sarcoidosis patient with small fiber neuropathy and cardiac symptoms with a cardiac sympathetic dysfunction, assessed with I-123 MIBG SPECT. After 5 months of treatment with carvedilol, which has besides adrenergic receptor blocking effects also antioxidant action, we saw a clear improvement of the cardiac sympathetic function demonstrated on a repeated I-123 MIBG SPECT. Future studies should explore the clinical relevance of the relation of oxidative stress, antioxidant therapy and cardiac dysfunction in sarcoidosis.
Department of Pharmacology and Toxicology, Faculty of Health, Medicine and Life Sciences, University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
The activity of antioxidants is frequently determined in competition assays. In these assays an antioxidant (A) and detector molecule (D) compete for the reactive species (R). The competitive inhibitory effect of A on the reaction of D with R is a measure of the antioxidant activity of A. In determining the activity of A, it is in general incorrectly assumed that the concentrations of A and D remain equal to the initial concentration. However, the principle of the assay is that some A and D is consumed assay and consequently the concentration of A and D will decrease during a competition assay, resulting in a deviation in the observed antioxidant activity. Computer modeling was used to obtain a graphical tool to estimate the extent of the deviation caused by the incorrect assumption that the concentrations of A and D do not decrease. Several competition assays are evaluated using this graphical tool, demonstrating that frequently inaccurate antioxidant activities have been reported. In general, differences between antioxidants are underestimated and the activity of all antioxidants shifts towards the antioxidant activity of D. A strategy is provided to improve the accuracy of a competition assay. To obtain accurate results in a competition assay, the reaction rate constant of the detector molecule with the reactive species should be comparable to that of the antioxidant. In addition, the concentration of reactive species should be as low as possible.
Antje R Weseler,
Liesbeth Geraets,
Harald J J Moonen,
Ralph J F Manders,
Luc J C van Loon,
Herman-Jan Pennings,
Emiel F M Wouters,
Aalt Bast,
Geja J Hageman
Department of Health Risk Analysis and Toxicology, Maastricht University Medical Centre+, Maastricht 6200 MD, The Netherlands. a.weseler@farmaco.unimaas.nl
Recently, we identified several flavonoids as inhibitors of the nuclear enzyme poly(ADP-ribose) polymerase (PARP)-1 in vitro and in vivo. PARP-1 is recognized as coactivator of nuclear factor-kappaB and plays a role in the pathophysiology of diseases with low-grade systemic inflammation, such as chronic obstructive pulmonary disease (COPD) and type 2 diabetes (T2D). In this study, we assessed the antiinflammatory effects of flavonoids with varying PARP-1-inhibiting effects in whole blood from male patients with COPD or T2D and healthy men. A total of 10 COPD, 10 T2D patients, and 10 healthy volunteers matched for age and BMI were recruited. Blood from each participant was exposed to 1 microg/L lipopolysaccharide (LPS) over 16 h with or without preincubation with 10 micromol/L of flavone, fisetin, morin, or tricetin. Concentrations of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6,-8, and -10 were measured in the supernatant. Preincubation with fisetin and tricetin strongly attenuated LPS-induced increases in concentrations of TNFalpha in blood from COPD patients [mean (+/- SEM):-41 +/- 4%(fisetin) and -31 +/- 4%(tricetin); P < .001] and IL-6 in blood from T2D patients [-31 +/- 5%(fisetin) and -29 +/- 6%(tricetin); P < or = .001]. Moreover, LPS-induced changes in TNFalpha and IL-6 concentrations were positively correlated with the extent of reduction by fisetin and tricetin. The PARP-1-inhibiting flavonoids fisetin and tricetin were able to attenuate LPS-induced cytokine release from leukocytes of patients with chronic systemic inflammation, indicating a potential application as nutraceutical agents for these patient groups.
Mesh-terms: Aged; Chromones :: pharmacology; Cytokines :: blood; Diabetes Mellitus, Type 2 :: blood; Enzyme Inhibitors :: pharmacology; Flavonoids :: pharmacology; Humans; Interleukin-1 :: blood; Interleukin-10 :: blood; Interleukin-8 :: blood; Lipopolysaccharides :: pharmacology; Male; Middle Aged; Poly(ADP-ribose) Polymerases :: antagonists & inhibitors; Pulmonary Disease, Chronic Obstructive :: blood; Tumor Necrosis Factor-alpha :: blood;
Liesbeth Geraets,
Astrid Haegens,
Karen Brauers,
Jane A Haydock,
Juanita H J Vernooy,
Emiel F M Wouters,
Aalt Bast,
Geja J Hageman
Department of Pharmacology and Toxicology, Maastricht University Maastricht, The Netherlands. liesbeth.geraets@rivm.nl
In the present study, the anti-inflammatory effects of the flavonoids flavone, fisetin and tricetin were evaluated in a mouse model of LPS-induced acute pulmonary inflammation. The flavonoid fisetin significantly reduced lung myeloperoxidase-levels and gene-expression of inflammatory mediators such as IL-6, TNF-alpha, IL-1beta, MIP-1alpha and MIP-2. The LPS-induced gene transcription of HO-1 and SOD2 was also significantly reduced by fisetin. Overall, the anti-inflammatory effects of fisetin in this in vivo model were much more pronounced as compared to the observed effects of flavone or tricetin and the anti-inflammatory glucocorticoid dexamethasone. The results of this study indicate that flavonoids such as fisetin might be potential candidates as pharmaceuticals or nutraceuticals in the treatment of pulmonary inflammatory diseases.
Mesh-terms: Animals; Anti-Inflammatory Agents, Non-Steroidal :: therapeutic use; Chromones :: therapeutic use; Flavonoids :: therapeutic use; Gene Expression; Heme Oxygenase-1 :: genetics; Inflammation Mediators :: antagonists & inhibitors; Inflammation Mediators :: metabolism; Interleukin-6 :: blood; Lipopolysaccharides :: immunology; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Peroxidase :: antagonists & inhibitors; Pneumonia :: drug therapy; Pneumonia :: immunology; Poly(ADP-ribose) Polymerases :: metabolism; Superoxide Dismutase :: genetics;
Department of Pharmacology and Toxicology, Faculty of Health, Medicine and Life Sciences, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands. shufan.qi@farmaco.unimaas.nl
Reactive oxygen species (ROS) have been implicated in the pathogenesis of fibrosis. However, it remains unclear which ROS is the major cause. We hypothesize that superoxide elicits specific toxicity to human lung fibroblasts and plays an important role in the development of pulmonary fibrosis. In this study, superoxide generated from xanthine and xanthine oxidase activated lung fibroblasts by increasing the release of TGF-beta1 and collagen. This was associated with increased levels of intracellular superoxide. SOD and tempol, by scavenging respectively extracellular and intracellular superoxide, prevented the activation of fibroblasts induced by exposure to exogenous superoxide, whereas catalase did not. Moreover, hydrogen peroxide did not activate fibroblasts. Apparently, superoxide rather than hydrogen peroxide is involved in the regulation of TGF-beta1 and collagen release in lung fibroblasts. The chloride channel blocker, DIDS, inhibited the increase of intracellular superoxide levels induced by exogenous superoxide and consequently prevented the activation of fibroblasts. This suggests that the cellular influx of superoxide through chloride channels is essential for superoxide-induced activation of fibroblasts. ERK1/2 and p38 MAPKs are involved in the intracellular pathway leading to superoxide-induced fibroblasts activation. Superoxide possesses until now undiscovered specific pro-fibrotic properties in human lung fibroblasts. This takes place via the cellular influx of superoxide through chloride channels rather than via the formation of hydrogen peroxide.
Mesh-terms: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid :: pharmacology; Apoptosis :: drug effects; Apoptosis :: physiology; Biological Markers :: metabolism; Caspase 3 :: metabolism; Cell Line; Cell Survival :: physiology; Chloride Channels :: antagonists & inhibitors; Chloride Channels :: metabolism; Collagen :: metabolism; Female; Fibroblasts :: drug effects; Fibroblasts :: metabolism; Humans; Lung :: cytology; Lung :: drug effects; Lung :: metabolism; Oxidative Stress :: physiology; Pulmonary Fibrosis :: chemically induced; Pulmonary Fibrosis :: metabolism; Reactive Oxygen Species :: toxicity; Superoxide Dismutase :: metabolism; Superoxides :: toxicity; Transforming Growth Factor beta1 :: metabolism;
